Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

The industry’s positioning in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent ... The consensus mark for CI’s 2025 earnings has moved 0.2% ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

For Immediate Release Chicago, IL – June 27, 2025 – Today, Zacks Equity Research discusses The Cigna Group CI, Humana Inc. HUM, Centene Corp. CNC and Molina Healthcare, Inc. MOH. Industry: HMO ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Centene shares closed at an eight-year low on Wednesday, marking their largest single-day plunge, after the U.S. health insurer withdrew its 2025 earnings forecast due to an expected revenue slump ...

The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...

Elevance Health reported $1.7 billion in profit during the second quarter, down 24% from Q2 2024, which was enough to drive ...

Peers of health insurer Centene (NYSE:CNC) traded lower on Wednesday after the company withdrew its 2025 earnings guidance, citing a higher-than-anticipated cost trend attributed to its Medicaid ...